Lower respiratory tract infections are associated with high morbidity and mortality and
significant clinical harm. Due to the limited ability of traditional pathogen detection methods …

Although the incidence of Pneumocystis pneumonia (PCP) has decreased since the
introduction of combination antiretroviral therapy, it remains an important cause of disease in …

From the first descriptions of HIV/AIDS, the lung has been the site most frequently affected by
the disease. Most patients develop a pulmonary complication during the history of HIV …

During the past 30 years, major advances have been made in our understanding of
HIV/AIDS and Pneumocystis pneumonia (PCP), but significant gaps remain. Pneumocystis …

As more original molecular protocols and subsequent modifications are described in the
literature, it has become difficult for those not directly involved in the development of these …

Pneumocystis, a unique atypical fungus with an elusive lifestyle, has had an important
medical history. It came to prominence as an opportunistic pathogen that not only can cause …

Introduction: Pneumocystis jirovecii is a ubiquitous fungus, which causes pneumonia in
humans. Diagnosis was hampered by the inability to culture the organism, and based on …

Summary Objectives The incidence of Pneumocystis jirovecii pneumonia (PCP) in patients
without HIV infection (non-HIV PCP) has been increasing along with the increased use of …

Pneumocystis is a genus of ascomycetous fungi that are highly morbid pathogens in
immunosuppressed humans and other mammals. Pneumocystis cannot easily be …

Objective To assess host factors in pneumocystis jirovecii pneumonia (PCP)–related
hospitalizations and compare outcomes between HIV and non-HIV patients. Methods Using …